Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,037 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Time-dependent change in relapse sites of renal cell carcinoma after curative surgery.
Noguchi G, Nakaigawa N, Taguri M, Tsutsumi S, Saito Y, Fukui S, Yasui M, Tokita T, Mitome T, Tatenuma T, Kuroda S, Abe K, Ueno D, Namura K, Umemoto S, Takizawa A, Ohta J, Ueki T, Watanabe T, Kobayashi K, Kondo K, Kishida T, Kanno H, Kitami K, Yamanaka T, Yao M. Noguchi G, et al. Among authors: tsutsumi s. Clin Exp Metastasis. 2018 Feb;35(1-2):69-75. doi: 10.1007/s10585-018-9883-0. Epub 2018 Mar 7. Clin Exp Metastasis. 2018. PMID: 29516208
A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
Kasahara R, Kawahara T, Ohtake S, Saitoh Y, Tsutsumi S, Teranishi JI, Miyoshi Y, Nakaigawa N, Yao M, Kobayashi K, Uemura H. Kasahara R, et al. Among authors: tsutsumi s. Biomed Res Int. 2017;2017:7981549. doi: 10.1155/2017/7981549. Epub 2017 Apr 13. Biomed Res Int. 2017. PMID: 28497065 Free PMC article. Clinical Trial.
A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy.
Saitoh-Maeda Y, Kawahara T, Miyoshi Y, Tsutsumi S, Takamoto D, Shimokihara K, Hayashi Y, Mochizuki T, Ohtaka M, Nakamura M, Hattori Y, Teranishi JI, Yumura Y, Osaka K, Ito H, Makiyama K, Nakaigawa N, Yao M, Uemura H. Saitoh-Maeda Y, et al. Among authors: tsutsumi s. BMC Urol. 2017 Sep 18;17(1):87. doi: 10.1186/s12894-017-0279-2. BMC Urol. 2017. PMID: 28923108 Free PMC article.
Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report.
Tokita T, Kawahara T, Ito Y, Tsutsumi S, Abe K, Namura K, Sano F, Shioi K, Takamoto D, Yumura Y, Nakaigawa N, Yao M, Uemura H, Wada H, Tsuura Y, Kobayashi K. Tokita T, et al. Among authors: tsutsumi s. Urol Case Rep. 2018 Mar 13;18:54-56. doi: 10.1016/j.eucr.2018.03.006. eCollection 2018 May. Urol Case Rep. 2018. PMID: 29785370 Free PMC article.
Does screening for prostate cancer improve cancer-specific mortality in Asian men? Real-world data in Yokosuka City 15 years after introducing PSA-based population screening.
Tabei T, Taguri M, Sakai N, Koh H, Yosida M, Fujikawa A, Nirei T, Tsutsumi S, Ito H, Furuhata S, Kawahara T, Miyoshi Y, Noguchi S, Uemura H, Kobayashi K. Tabei T, et al. Among authors: tsutsumi s. Prostate. 2020 Aug;80(11):824-830. doi: 10.1002/pros.23997. Epub 2020 May 20. Prostate. 2020. PMID: 32433780
C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma.
Noguchi G, Nakaigawa N, Umemoto S, Kobayashi K, Shibata Y, Tsutsumi S, Yasui M, Ohtake S, Suzuki T, Osaka K, Muraoka K, Hasumi H, Kondo K, Igarashi Y, Sasada T, Kishida T, Yao M. Noguchi G, et al. Among authors: tsutsumi s. Cancer Chemother Pharmacol. 2020 Jul;86(1):75-85. doi: 10.1007/s00280-020-04088-y. Epub 2020 Jun 14. Cancer Chemother Pharmacol. 2020. PMID: 32537714
1,037 results